Expert Details
Oncology, Hematology
ID: 735972
Ohio, USA
LEGAL BIO SKETCH: MEDICAL MALPRACTICE I served as expert witness in 2 malpractice cases in the setting of clinical management of early prostate cancer, dating to 2003 and 2005. For each, I wrote a declaration and was deposed. These cases were settled and did not go to trial.
INTELLECTUAL PROPERTY In 2014, I was retained, in a patent dispute where I served as an expert witness on the side of the patent owner. The case involved a patent dispute, which is used to treat 1.) hypercalcemia and 2.) treat bone metastases. In 2016, I functioned as an expert witness in a patent despite where the petitioner and ___was the patent owner and the drug in question was Fulvestrant, an estrogen receptor antagonist. After submitting a declaration, the case was settled. I also worked on a case where I wrote several declarations and assume that the case was settled since this work was completed in 2015. In 2017, I was retained as an expert witness in a patent dispute by the firm on the side of (patent owner) vs (petitioner). I have continued to assist with their patents and at present, I previously this year, assisted as expert witness in a patent dispute. At present, I am not retained or under contract. *More examples available upon request.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1982 | Degree: MD | Subject: Medicine | Institution: Tufts University School of Medicine, Boston MA |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2015 to Present | Employer: Undisclosed | Title: Professor of Medical Oncology and CEO | Department: Medical Oncology and Hematology/Oncology |
Responsibilities:I am CEO of a combo medical oncology/Hematology practice where 1.) I provide second opinion consultations on rare and/or complicated cancer cases as well as 2.) functioning as a consultant to pharma and financial services with regard to medical intelligence and finally, 3.) serve as an expert witness in numerous cases from malpractice to intellectual property to breach of contract. |
|||
| Years | Employer | Title | Department |
| Years: 2013 to 2014 | Employer: Dana Farber Cancer Center | Title: Clinician | Department: Hematology/Oncology |
Responsibilities:I functioned as a Hematologist/Oncologist, caring for patients with solid tumors, hematologic malignancies and non-malignant hematologic disorders. |
|||
| Years | Employer | Title | Department |
| Years: 2012 to 2013 | Employer: Saint Louis University Hospital and Medical Center | Title: Professor of Medicine | Department: Hematology/Oncology |
Responsibilities:I functioned as a Hematologist/Oncologist, caring for patients with solid tumors, hematologic malignancies and non-malignant hematologic disorders. |
|||
| Years | Employer | Title | Department |
| Years: 2003 to 2012 | Employer: University of Cincinnati Medical Center and the Barrett Cancer Center | Title: Associate Professor of Medicine/Hematology/Oncology | Department: Department of Hematology/Oncology |
Responsibilities:I functioned as a Hematologist/Oncologist, caring for patients with solid tumors, hematologic malignancies and non-malignant hematologic disorders. |
|||
Additional Experience
| Expert Witness Experience |
|---|
| LEGAL BIO SKETCH: Expert M.D. I. MEDICAL MALPRACTICE I served as expert witness in 2 malpractice cases in the setting of clinical management of early prostate cancer, dating to 2003 and 2005. For each, I wrote a declaration and was deposed. These cases were settled and did not go to trial. II. INTELLECTUAL PROPERTY In 2014, I was retained by K and L Gate, the petitioner, in a patent dispute where I served as an expert witness on the side of Par Sterile Products LLC/ACCORD HEALTH CARE INC, vs Novartis, the patent owner. The case involved a patent dispute over the bisphosphonate, Zometa, which is used to treat 1.) hypercalcemia and 2.) treat bone metastases. I am no longer working for K and L Gates. In 2016, I functioned as an expert witness for Perkins and Coie in a patent despite where Mylan Pharmaceuticals INC was the petitioner and ASTRAZENICA AB was the patent owner and the drug in question was Fulvestrant, an estrogen receptor antagonist. After submitting a declaration, the case was settled. I also worked for Perkins and Coie on a case where the petitioner was Dr. Reddy’s Lab and the patent owner was Celgene. I wrote several declarations and assume that the case was settled since this work was completed in 2015. I no longer work for Perkins and Coie. In 2017, I was retained as an expert witness in a patent dispute by the firm of Wilmer/Hale on the side of Genentech (patent owner) vs Hospira (petitioner) regarding Herceptin. I have continued to assist Wilmer/Hale with their Herceptin patents and at present, I previously this year, assisted as expert witness in a patent dispute between on the side of Genentech vs AMGEN. At present, I am not retained or under contract with Wilmer/Hale In early 2018, I was retained by the Sprigings Intellectual Property Law Firm of Toronto, Canada in a patent dispute between Celgene, patent owner and Dr. Reddy’ laboratory, the petitioner, involving multiple patents for the drug Revlamid which is utilized to treat a variety of hematologic malignancies. After providing written declarations, I was informed by Sprigings that Dr. Reddy decided NOT to pursue the case to an inter-parties review. I am no longer working for Sprigings. in 2018, I was retained by Irell and Manella on the side of Genentech/Biogen, the patent owner, in a patent dispute with Pfizer, the petitioner regarding the cancer drug RITUXAN which is used to treat B-cell malignancies. I wrote a declaration, was deposed. At present, I am not under contract or retained by Irell and Manella. III. BREACH OF CONTRACT In 7/2019 I was retained by Diamond and McCarthy in a breach of contract dispute on the side of AURORA BIOTECH vs Baylor University. At present, I am working on this case. |
Career Accomplishments
| Associations / Societies |
|---|
| Professor of Medical Oncology/Hematology for 33 years, published over 100 clinical papers in peer reviewed journals, served as principal investigator in over 100 clinical trials, served as panelist for NCCN, key-opinion leader in medical oncology/Hematology, served as consultant to Pharma and financial services with regard to medical intelligence. Professional Societies: American Society of Hematology, Member American Society of Clinical Oncology, Member Cancer and Leukemia B (CALGB), Member Eastern cooperative Group (ECOG), Member Phi Delta Epsilon Fraternity, Member American College of Physicians, Member National Kidney Cancer Association, Member, Editorial Advisory Board SWOG, Member Editorial Activities: Cancer Transfusion Southern Journal of Medicine Journal of Urology American Journal of Medical Sciences |
| Licenses / Certifications |
|---|
| MD. Liceensed in OH and NY state (active). Inactive in CT and MO |
| Awards / Recognition |
|---|
| Webster Prize Amherst College, Undergraduate Thesis Simpson Fellowship, Tufts University School of Medicine, Scholarship based on GPA Hampden Scholarship, Tuft University School of Medicine, Scholarship based on GPA Third Prize awarded at basic investigators research symposium, Albert Einstein college of Medicine, Third prize for best scientific paper Certificate of recognition, Roswell Park, Excellence in clinical practice |
| Publications and Patents Summary |
|---|
| Over 100 peer reviewed publications in the area of Hematology and Medical Oncology. |
Fields of Expertise
oncology, hematologic neoplasm, hematologic disease, breast cancer, cancer immunotherapy, bone cancer, gastrointestinal cancer, lung cancer, blood clotting disease, malignant melanoma, kidney cancer, head and neck cancer, brain tumor, sarcoma, adoptive cellular immunotherapy, leukemia, lymphoproliferative disorder, chronic lymphocytic leukemia, lymphoma, bladder cancer, prostate cancer, gynecologic oncology, skin cancer, cancer biology, cancer causation, cancer chemoprevention, cancer chemotherapeutic agent, cancer chemotherapy, cancer diagnosis, cancer epidemiology, cancer prognosis, cancer research, cancer treatment, cancer immunology, cancer, cancer physiology, intestinal cancer, colon cancer, colon cancer screening, colorectal cancer, liver cancer, missed cancer diagnosis, occupational cancer, oral cancer, pancreatic cancer, stomach cancer, skin cancer treatment, urologic cancer, cancer risk, precancerous condition, genetic disease, genetic mutation process